25 August 2023 - AstraZeneca said on Friday it has sued the US Government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices.

The British drug maker, which filed its complaint in a Delaware district court, joins other drug makers and business groups claiming that the program would restrict the development of new medicines.

Read Reuters article